Projects per year
Personal profile
Research Interests
Dr. Thakur Raghu Raj Singh is Reader in Pharmaceutics in the School of Pharmacy, Queen's University Belfast. He has obtained his Ph.D. in Drug Delivery from School of Pharmacy, Queens University Belfast (2009), M.Sc in Pharmaceutical Sciences from University Science Malaysia (2006) and B.Pharm from Jawaharlal Nehru Technological University, India (2002).
Dr. Thakur’s research interests are in the design and physicochemical characterisation of advanced polymeric drug delivery systems for ocular, transdermal and topical applications. In particular, his current research involves the fabrication and design of novel long-acting injectable and implantable drug delivery systems for treating back of the eye disorders. His research on the treatment of eye disorders has led to the formation of Re-Vana Therapeutics Ltd., where he is currently serving as a Chief Security Officer (CSO). Re-Vana Therapeutics is an ocular pharmaceutical & drug delivery company focused on addressing ophthalmic conditions such as age-related macular degeneration (AMD), diabetic retinopathy (DR), glaucoma and other ocular infections.
He is the Chair for Ocular Delivery (OcD) Focus Group supported by the mission of Controlled Release Society (CRS) that engages researchers, industry representatives, and regulatory experts in the advancement of technologies designed to protect or restore vision
He has authored over 150 scientific publications, including 54 peer-reviewed research papers, 10 book chapters and 4 textbooks. He has been an invited speaker at a number of national/international meetings. He is currently Editorial Board member of the International Journal of Pharmacy & Pharmacology, Chronicles of Pharmacy and SCIENCEDOMAIN international, and Scientific advisor for Journal of Pharmaceutical Sciences. He is a reviewer for several high impact journals.
Fingerprint Dive into the research topics where Thakur Raghu Raj Singh is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 10 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
R6617PMY: Ocular Research By Integrated Training And Learning
Singh, T. R. R., Donnelly, R. & Larrañeta, E.
03/05/2019 → …
Project: Research
R6567PMY: Drug Discovery and Delivery NEtwork for Oncology and Eye Therapeutics
25/04/2017 → …
Project: Research
R1526PMY: Development and Preclinical Evaluation of Novel Long-acting Injectable Ocular Implants
22/05/2015 → …
Project: Research
Research Output
A validated size exclusion chromatography method coupled with fluorescence detection for rapid quantification of bevacizumab in ophthalmic formulations
Jirjees, F., Soliman, K., Wang, Y., Sonawane, R., Sheshala, R., Jones, D. & Singh, T. R. R., 22 May 2019, In : Journal of Pharmaceutical and Biomedical Analysis.Research output: Contribution to journal › Article
Evaluation of Microneedles-assisted in situ Depot Forming Poloxamer gels for Sustained Transdermal Drug Delivery
Khan, S., Usman Minhas, M., Tekko, I. A., Donnelly, R. F. & Thakur, R., 23 Jan 2019, In : Drug Delivery and Translational Research.Research output: Contribution to journal › Article
Open Access
File
4
Citations
(Scopus)
186
Downloads
(Pure)
How innovative drug delivery devices can help realise clinical utility of new effective therapies
Lamprou, D. A., Singh, T. R. R., Larraneta, E. & Donnelly, R. F., 06 Nov 2019, In : Expert Opinion on Drug Delivery. 16, 12Research output: Contribution to journal › Editorial
In situ forming photocrosslinked biodegradable implants for sustained delivery of proteins
Thakur, R., Wang, Y., Soliman, K., Sonawane, R. & Jones, D., Apr 2019.Research output: Contribution to conference › Poster
Novel biodegradable photocrosslinked implants for sustained ocular delivery of triamcinolone acetonide
Thakur, R., Wang, Y., Sonawane, R., Soliman, K. & Jones, D., Apr 2019.Research output: Contribution to conference › Poster
Prizes
Best Oral Presentation, British Pharmaceutical Conference, Manchester, U.K, September 2008.
Thakur Raghu Raj Singh (Recipient), 2008
Prize: Prize (including medals and awards)
Best Poster Prize at 2nd Microneedle Conference, Cork, Ireland, May 2012.
Thakur Raghu Raj Singh (Recipient), 2012
Prize: Prize (including medals and awards)
Best Poster Prize at Skin forum conference in Versailles, France, March 2009.
Thakur Raghu Raj Singh (Recipient), 2009
Prize: Prize (including medals and awards)
Bets Oral Presentation at Vision TRG Conference
Thakur Raghu Raj Singh (Recipient), 14 Mar 2014
Prize: Prize (including medals and awards)
Activities
Sustained Release of Small and Large Molecules Using Novel Ocular Drug Delivery Systems
Thakur Raghu Raj Singh (Advisor)07 Nov 2019 → 09 Nov 2019
Activity: Talk or presentation types › Oral presentation
The Association for Research in Vision and Ophthalmology 2019
Thakur Raghu Raj Singh (Participant), Yujing Wang (Participant), Karim Soliman (Participant), Rahul Sonawane (Participant), David Jones (Participant)28 Apr 2019 → 02 May 2019
Activity: Participating in or organising an event types › Participation in conference
Ocular Drug Delivery – current challenges and innovative solutions
Thakur Raghu Raj Singh (Advisor)25 Nov 2019 → 26 Nov 2019
Activity: Talk or presentation types › Oral presentation
41st All Ireland Schools of Pharmacy conference
Wenrui Zhang (Participant), Wafa Al-Jamal (Participant), Thakur Raghu Raj Singh (Participant)17 Apr 2019 → 18 Apr 2019
Activity: Participating in or organising an event types › Participation in conference
Novel technologies for addressing unmet needs in drug delivery to the eye
Thakur Raghu Raj Singh (Advisor)13 Feb 2019
Activity: Talk or presentation types › Invited talk
Press / Media
Re-Vana Therapeutics Names Renowned International Experts to Inaugural Scientific Advisory Board
04/06/2019
1 item of Media coverage
Press/Media: Other